Evidence map›Paper›PMID 32087171›Full record

ArticleThe Lancet. Global health2020

Burden of disease in francophone Africa, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Charbel El Bcheraoui, Honoré Mimche, Yodé Miangotar, Varsha Sarah Krish, Faye Ziegeweid, Kris J Krohn, Martin Herbas Ekat, Jobert Richie Nansseu, Zacharie Tsala Dimbuene, Helen Elizabeth Olsen and 7 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet. Global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
10.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. IL-15-induced CD38Clinical & translational immunology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 7 countries.

Charbel El BcheraouiInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA; Evidence-Based Public Health, Centre for International Health Protection, Robert Koch Institute, Berlin, Germany. Electronic address: el-bcheraouic@rki.de.
Honoré MimcheInstitut de Formation et de Recherche Démographiques, Université de Yaoundé II, Yaoundé, Cameroon.
Yodé MiangotarFaculté des Sciences Humaines et Sociales, Université de N'Djaména, N'Djaména, Chad.
Varsha Sarah KrishInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Faye ZiegeweidInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Kris J KrohnInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Martin Herbas EkatNational AIDS Control Program, Ministry of Health and Population, Brazzaville, Congo.
Jobert Richie NansseuDepartment for the Control of Disease, Epidemics and Pandemics, Ministry of Public Health, Yaoundé, Cameroon; Department of Public Heath, Faculty of Medicine and Biomedical Sciences, Université de Yaoundé I, Yaoundé, Cameroon.
Zacharie Tsala DimbueneDepartment of Population Sciences and Development, Faculty of Economics and Management, University of Kinshasa, Kinshasa, Democratic Republic of the Congo; Microdata Access Division, Statistics Canada, Ottawa, ON, Canada.
Helen Elizabeth OlsenGlobal Health, Bill & Melinda Gates Foundation, Seattle, WA, USA.
Roger C K TineService de Parasitologie, Faculté de Médecine, de Pharmacie et d'Odontologie, Université Cheikh Anta Diop, Dakar, Senegal.
Christopher M OdellInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Christopher E TroegerInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Nicholas J KassebaumInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA, USA.
Tamer FaragInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Simon I HayInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.
Ali H MokdadInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.
Institute for Health Metrics and Evaluation · USUniversity of Washington · USBill & Melinda Gates Foundation · USCheikh Anta Diop University · SNMinistry of Public Health · CMRobert Koch Institute · DEUniversité de Yaoundé I · CMUniversity of Kinshasa · CDUniversity of N'Djamena · TD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeer-reviewed literature on health is almost exclusively published in English, limiting the uptake of research for decision making in francophone African countries. We used results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to assess the burden of disease in francophone Africa and inform health professionals and their partners in the region.

methodsWe assessed the burden of disease in the 21 francophone African countries and compared the results with those for their non-francophone counterparts in three economic communities: the Economic Community of West African States, the Economic Community of Central African States, and the Southern African Development Community. GBD 2017 employed a variety of statistical models to determine the number of deaths from each cause, through the Cause of Death Ensemble model algorithm, using CoDCorrect to ensure that the number of deaths per cause did not exceed the total number of estimated deaths. After producing estimates for the number of deaths from each of the 282 fatal outcomes included in the GBD 2017 list of causes, the years of life lost (YLLs) due to premature death were calculated. Years lived with disability (YLDs) were estimated as the product of prevalence and a disability weight for all mutually exclusive sequelae. Disability-adjusted life-years (DALYs) were calculated as the sum of YLLs and YLDs. All calculations are presented with 95% uncertainty intervals (UIs). A sample of 1000 draws was taken from the posterior distribution of each estimation step; aggregation of uncertainty across age, sex, and location was done on each draw, assuming independence of uncertainty. The lower and upper UIs represent the ordinal 25th and 975th draws of each quantity and attempt to describe modelling as well as sampling error.

findingsIn 2017, 779 deaths (95% UI 750-809) per 100 000 population occurred in francophone Africa, a decrease of 45·3% since 1990. Malaria, lower respiratory infections, neonatal disorders, diarrhoeal diseases, and tuberculosis were the top five Level 3 causes of death. These five causes were found among the six leading causes of death in most francophone countries. In 2017, francophone Africa experienced 53 570 DALYs (50 164-57 361) per 100 000 population, distributed between 43 708 YLLs (41 673-45 742) and 9862 YLDs (7331-12 749) per 100 000 population. In 2017, YLLs constituted the majority of DALYs in the 21 countries of francophone Africa. Age-specific and cause-specific mortality and population ageing were responsible for most of the reductions in disease burden, whereas population growth was responsible for most of the increases.

interpretationFrancophone Africa still carries a high burden of communicable and neonatal diseases, probably due to the weakness of health-care systems and services, as evidenced by the almost complete attribution of DALYs to YLLs. To cope with this burden of disease, francophone Africa should define its priorities and invest more resources in health-system strengthening and in the quality and quantity of health-care services, especially in rural and remote areas. The region could also be prioritised in terms of technical and financial assistance focused on achieving these goals, as much as on demographic investments including education and family planning.

fundingBill & Melinda Gates Foundation.

Indexed as

Cost of IllnessAfricaGlobal Burden of DiseaseHumans

Identifiers

PMID32087171
PMCPMC7034333
OpenAlexW3006769559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.